Aflac (AFL) Insider Joseph Moskowitz Sells $1.4M of Stock
Aflac insider Joseph Moskowitz parted with 12,370 shares of stock in a transaction valued at roughly $1.44 million.
Reviewed by automated data checks against the source filing. How we make and check alerts
Joseph Moskowitz sold 12,370 shares of Aflac Incorporated ($AFL) at an average price of $116.54, worth about $1.44 million, on June 22, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $AFL is up 3.0% after 1 week, up 6.0% after 1 month and up 3.5% to date (from the $115.97 close on Jun 22, 2026).
AFL
Aflac Incorporated
Key Points
- Joseph Moskowitz sold 12,370 shares of Aflac Incorporated on June 22, 2026, at an average price of $116.54 per share.
- The total value of the insider stock sale reached approximately $1.44 million.
- Aflac shares trade with a trailing price-to-earnings ratio of 12.43 and a dividend yield of 2.1%.
Get $AFL trade alerts by text
We text you when insiders, Congress or big funds trade $AFL. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Aflac Incorporated alert may contain errors. Disclosures
Insider Buying and Selling at Aflac Incorporated
Joseph Moskowitz executed a sale of Aflac Incorporated (NYSE:AFL) shares on June 22, 2026, according to a filing with the SEC. The transaction involved 12,370 shares sold at an average price of $116.54. The total value of the shares traded amounted to approximately $1.44 million. This filing captures a specific snapshot of insider activity and does not reflect any subsequent trades made by the individual.
Recent Insider Activity at Aflac
Insider transactions at the insurance provider have included multiple sales by major holders alongside transactions from company insiders. Japan Post Holdings Co., Ltd. parted with 55,000 shares on October 14, 2026, at an average price of $117.79 for a total value of about $6.48 million. Earlier in the month on October 13, 2026, Japan Post Holdings sold 42,000 shares valued at roughly $4.89 million at an average price of $116.38. Back on June 22, 2026, Joseph Moskowitz also acquired 20,303 shares at a price of $44.59 per share, totaling about $905,311. Additional planned sales by Japan Post Holdings occurred in mid-June, including transactions of 3,300 shares on June 18, 2026, at $116.92, 26,300 shares on June 17, 2026, at $116.62, and 30,000 shares on June 16, 2026, at $117.39.
Aflac Stock Performance and Valuation
Aflac shares have hovered near recent price points, trading on Wednesday with a spot price around $119.93. The stock moves within a 52-week range defined by a low of $105.43 and a high of $130.22. Short-term and long-term trend lines show the 50-day moving average at $120.60 and the 200-day moving average resting near $114.85. The company currently maintains a price-to-earnings ratio of 12.43.
Recent Earnings and Financial Health
Aflac generated $18.07 billion in revenue over the reporting period, accompanied by a net profit margin of 26.91% and a return on equity of 16.91%. Earnings per share stand at $9.27. The company's next scheduled earnings report is slated for November 4, 2026, after the market closes.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
2 target raises vs 2 cuts.
-
EPS & revenue
EPS missed estimates by 4.4%. Revenue beat estimates by 1.1%.
-
Profit surprise
Operating income beat by 13 percent.
-
Pre-earnings setup
Bar was low, analysts cautious going in.
-
Analyst signal
2 target raises, 2 target cuts.
-
Earnings quality
Gross margin up 43.4 points. Operating margin up 24.2 points.
Earnings Call Summary
Aflac Japan delivered strong sales growth of 25.5 percent in the quarter, driven by new medical and cancer insurance products, though underlying earned premiums still declined 1.3 percent due to lapses of paid-up policies. In the United States, net earned premiums grew 3.5 percent with solid persistency of 79.3 percent. Management noted that Japan would need about 80 billion yen in annual sales to reach flat earned premium growth, versus 74 billion achieved in 2025.
Guidance Aflac expects Japan benefit ratio between 60 percent and 63 percent for the full year, roughly in line with first quarter results. For the United States, they forecast a benefit ratio of 42 percent to 52 percent. The company plans to continue share buybacks and dividend increases, returning $1.3 billion to shareholders in the first quarter alone.
Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.
Dividend Offerings
Shareholders receive an annual dividend of $2.44 per share, translating to a dividend yield of 2.1%. The payout ratio sits comfortably at 25.67% of earnings, indicating strong coverage by company profits.
Analysts Set New Price Targets
Wall Street firms continue to update their outlooks on the insurance stock. On October 15, 2026, JP Morgan maintained a Neutral rating with a target price of $119.00. Wells Fargo kept an Equal-Weight rating on October 12, 2026, moving its target to $116.00 after previously holding a $122.00 target on August 19, 2026. Keefe, Bruyette & Woods maintained a Market Perform rating on October 9, 2026, with a target of $120.00. Mizuho kept an Underperform rating on October 7, 2026, lowering its target to $107.00. Barclays maintained an Underweight rating on October 7, 2026, shifting its target to $101.00. UBS maintained a Neutral rating on October 6, 2026, with a target of $125.00. Wolfe Research initiated coverage with an Underperform rating and a $103.00 target on August 19, 2026. Across the broader analyst community, the consensus target mean price rests at $118.53 based on 15 analyst opinions, with individual targets ranging from a low of $99.00 to a high of $138.00.
Overview of Aflac Incorporated
Aflac Incorporated provides supplemental health and life insurance products through its primary operating units, Aflac Japan and Aflac U.S. The company offers a wide array of coverage options ranging from cancer and medical plans to accident, disability, and dental insurance, serving individual policyholders and corporate clients alike.
What to Watch at Aflac Incorporated
Investors will look toward Aflac's upcoming earnings announcement on November 4, 2026, for fresh insights into financial health and operational margins. Monitoring subsequent Form 4 filings will also reveal whether other corporate insiders or major institutional stakeholders adjust their equity positions following these recent transactions.
Related Filing Alerts
Source: Joseph Moskowitz's Form 4 filing on $AFL (Jun 22, 2026). Find the original filing: AFL Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts